Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Lucid Group are shortlisted in three different categories at this year’s PMEA programme

October 16, 2018 |  

- PMLiVE

Lucid’s talent for working together with their clients to create magical programmes is clear to see as they celebrate three of their campaigns making the 2018 PMEA finals, well as making the cut for PMEA Support Agency of Year.

Jan Steele, Lucid Group COO and Co-founder commented, “We are extremely proud of our client partnerships. By continuing to push boundaries and creating industry-leading medical communications, we have, together, been able to transform the lives of those we touch. I am thrilled that their work has been shortlisted at this year’s PMEA.”

The PMEA programme aims to recognise work that delivers clearly identifiable benefits and improved outcomes for patients. The winners will be announced at the awards ceremony on Thursday 22nd November at The Tower – A Guoman Hotel.

More details about the shortlisted campaigns can be found below:

Excellence in Rare Diseases and Orphan Drugs:            

  • Revolutionising management of hidradenitis suppurativa in Europe: Why? What? How?
  • Advancing Science in a Rare Disease – A Cost Effective Clinical Decision Support Programme for Cystinosis.

Excellence in Healthcare Professional Education and Support Programmes:    

  • OptiMiSe: Delivering patient-centric management in MS through clinical behaviour change.

PMEA Support Agency of the Year:

  • LUCID : THE TRANSFORMATION

This content was provided by Lucid Group Communications Limited

Company Details

- PMLiVE

Lucid Group Communications Limited

Email
Website

 Latest Content from  Lucid Group Communications Limited 

My Lucid journey from PMW to Head of Medical

Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced...

Listen, learn and lift off

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the...

Launch excellence

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Meet The Lucid Group Talent Team

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 1)

Extraordinary lives: advancing change in rare diseases (Part 1)

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...

International Women's Day 2022 #BreakTheBias

Today is International Women’s Day. This day is about gender equality, which, to be achieved, must involve the calling out of gender bias, discrimination and stereotyping.Individually, we're all responsible for...